Willis Towers Watson Public (NASDAQ:WTW) Price Target Raised to $455.00

Willis Towers Watson Public (NASDAQ:WTW) had its target price lifted by TD Cowen from $391.00 to $455.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Several other brokerages have also recently commented on WTW. Truist Financial upped their target price on Willis Towers Watson Public from $320.00 to $400.00 and gave the company a “buy” rating in a report on Friday, July 31st. UBS Group raised their price target on shares of Willis Towers Watson Public from $382.00 to $405.00 and gave the stock a “buy” rating in a report on Monday, August 3rd. Weiss Ratings restated a “hold (c)” rating on shares of Willis Towers Watson Public in a research report on Wednesday, August 12th. The Goldman Sachs Group upped their price objective on shares of Willis Towers Watson Public from $316.00 to $385.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Finally, Morgan Stanley increased their price objective on shares of Willis Towers Watson Public from $315.00 to $350.00 and gave the stock an “equal weight” rating in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, Willis Towers Watson Public currently has a consensus rating of “Moderate Buy” and a consensus target price of $369.38.

Willis Towers Watson Public Price Performance

WTW stock opened at $341.99 on Thursday. The company has a market capitalization of $31.76 billion, a P/E ratio of 21.03, a PEG ratio of 0.98 and a beta of 0.42. The company has a fifty day moving average price of $299.87 and a 200-day moving average price of $288.49. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.68 and a current ratio of 1.68. Willis Towers Watson Public has a 52-week low of $240.61 and a 52-week high of $352.79.

Willis Towers Watson Public (NASDAQ:WTW) last announced its earnings results on Thursday, July 30th. The company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.12 by $0.23. The business had revenue of $2.47 billion during the quarter, compared to analyst estimates of $2.42 billion. Willis Towers Watson Public had a return on equity of 22.19% and a net margin of 15.49%.Willis Towers Watson Public’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period last year, the company earned $2.86 EPS. As a group, equities analysts expect that Willis Towers Watson Public will post 19.82 EPS for the current year.

Institutional Investors Weigh In On Willis Towers Watson Public

A number of hedge funds have recently added to or reduced their stakes in WTW. Raiffeisen Bank International AG lifted its stake in Willis Towers Watson Public by 37.8% in the second quarter. Raiffeisen Bank International AG now owns 124 shares of the company’s stock valued at $33,000 after buying an additional 34 shares during the period. AlTi Global Inc. grew its position in shares of Willis Towers Watson Public by 1.1% during the 4th quarter. AlTi Global Inc. now owns 3,302 shares of the company’s stock worth $1,088,000 after buying an additional 36 shares during the period. Larson Financial Group LLC grew its position in shares of Willis Towers Watson Public by 72.5% during the 4th quarter. Larson Financial Group LLC now owns 88 shares of the company’s stock worth $29,000 after buying an additional 37 shares during the period. Crossmark Global Holdings Inc. grew its position in shares of Willis Towers Watson Public by 1.3% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 3,064 shares of the company’s stock worth $801,000 after buying an additional 38 shares during the period. Finally, 44 Wealth Management LLC increased its stake in shares of Willis Towers Watson Public by 1.3% in the 4th quarter. 44 Wealth Management LLC now owns 2,939 shares of the company’s stock valued at $966,000 after acquiring an additional 39 shares in the last quarter. 93.09% of the stock is currently owned by institutional investors.

Key Stories Impacting Willis Towers Watson Public

Here are the key news stories impacting Willis Towers Watson Public this week:

• Positive Sentiment: TD Cowen raised its price target to $455 from $391 and reiterated a “Buy” rating. The new target implies substantial upside from recent trading levels and provides a positive valuation signal for WTW. TD Cowen raises Willis Towers Watson price target
• Positive Sentiment: Zacks Research increased several earnings forecasts for WTW. FY2026 EPS was raised to $19.73 from $19.51, while FY2027 EPS increased to $22.32 from $21.71. Estimates for Q1 2027, Q3 2027 and Q4 2027 were also raised, suggesting improved expectations for longer-term earnings growth. The current full-year consensus estimate is $19.77 per share. Zacks Research earnings estimate revisions for Willis Towers Watson
• Positive Sentiment: Persistent health-care cost inflation could support demand for WTW’s services. Aon expects U.S. employer health-care costs to rise 9.5% in 2027, increasing pressure on employers’ benefits budgets and potentially driving demand for benefits consulting, cost containment and risk-management solutions. Aon health-cost inflation outlook
• Neutral Sentiment: The earnings revisions were mixed. Zacks lowered its Q3 2026 EPS forecast to $3.51 from $3.56, although this was more than offset by increases to later-quarter and full-year estimates.

About Willis Towers Watson Public

Willis Towers Watson Public (NASDAQ: WTW) is a global advisory, broking and solutions company that helps organizations manage risk, optimize benefits and cultivate talent. The firm combines insurance brokerage and risk management capabilities with human capital and benefits consulting, actuarial and analytics services, and technology-enabled solutions. Willis Towers Watson serves a broad client base that includes multinational and mid-sized corporations, public sector organizations, insurers and investment managers.

The company’s core activities encompass commercial and reinsurance brokerage, risk transfer and risk-financing advice, and claims advocacy, alongside employee benefits and retirement consulting.